Login / Signup
Edward H van der Horst
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Social Media
Lymph Node Metastasis
Long Non Coding Rna
Cancer Therapy
Top Venues
Antibodies (Basel, Switzerland)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
F Donelson Smith
,
Robert H Pierce
,
Thomas Thisted
,
Edward H van der Horst
Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics.
Antibodies (Basel, Switzerland)
12 (3) (2023)